PathMaker Neurosystems Inc.
PathMaker is a near-commercial stage neuromodulation company developing non-invasive devices to treat Spasticity and ALS
PathMaker is a near-commercial stage neuromodulation company developing non-invasive devices to treat Spasticity and ALS
PathMaker Neurosystems Inc. is a near-commercial stage neuromodulation company that aims to develop non-invasive devices to treat Spasticity and ALS. The company's flagship product, MyoRegulator, is the world's first non-invasive neuromodulation device for the treatment of muscle spasticity. PathMaker is headquartered in Boston (US) and Paris (France), and is focused on rapidly bringing to market novel, breakthrough approaches to non-invasive treatment of serious neurological disorders. Founded in 1907, the company operates within the Biotechnology and Health Care industries, with its most recent $2.16M grant investment, obtained from the U.S. Department of Defense on 05 June 2024.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $2.16M | 1 | U.S. Department of Defense | 05 Jun 2024 |
No recent news or press coverage available for PathMaker Neurosystems Inc..
We care about your data, and we'd love to use cookies make your experience better.
